Meeting
2020 ASCO Quality Care Symposium
RELEVANT study: Patient (Pt) and physician (PI) perspectives on meaningful outcomes in advanced pancreatic ductal adenocarcinoma (PDAC).
Authors
Rille Pihlak
The University of Manchester/The Christie NHS Foundation Trust, Manchester, United Kingdom
Rille Pihlak, Melissa Frizziero, Soo Yit Gustin Mak, Christina Nuttall, Angela Lamarca, Richard Hubner, Janelle Yorke, Juan W. Valle, Mairead Geraldine McNamara
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
On-Demand Poster Session: Patient Experience
Track
Patient Experience
Sub Track
Communication and Shared Decision-Making Research
Citation
J Clin Oncol 38, 2020 (suppl 29; abstr 150)
DOI
10.1200/JCO.2020.38.29_suppl.150
Abstract #
150
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
The prognostic value of mutational signatures in pancreatic cancer.
First Author: Nicholas Light
Poster
2023 ASCO Annual Meeting
A decision-making tool for first-line treatment in advanced non–small-cell lung cancer based on plasma proteome biomarkers.
First Author: Itamar Sela
Poster
2022 ASCO Annual Meeting
Comparison of systematic inflammatory prognostic scores in patients with advanced pancreatic adenocarcinoma.
First Author: Lucy Xiaolu Ma
Poster
2021 Gastrointestinal Cancers Symposium
Molecular profiling of advanced pancreatic ductal adenocarcinoma (PDAC): Role of ctDNA.
First Author: Angela Lamarca